Chlorpromazine hepatotoxicity manifested by a selective and sustained rise of serum alkaline phosphatase activity
Tóm tắt
A patient with liver injury, probably due to chlorpromazine toxicity, is presented. Unusual features of this patient's illness included an extremely high and persistent elevation of alkaline phosphatase level without hyperbilirubinemia and lack of centrilobular bile stasis on liver biopsy.
Tài liệu tham khảo
Dickes, R., Schinker, V., andDeutsch, L. Serial liver function and blood studies in patients receiving chlorpromazine.New England J. Med. 256: 1, 1957.
Shay, H., andSiplet, H. Study of chlorpromazine jaundice, its mechanism and prevention.Gastroenterology 32:571, 1957.
Zimmerman, H. J. Clinical and laboratory manifestation of hepatotoxicity.Ann. N. Y. Acad. Sci. 104:954, 1963.
Werther, J. L., andKorelitz, B. I. Chlorpromazine jaundice.Amer. J. Med. 22: 351, 1957.
Ross, R., Iber, F. L., andHarvey, A. M. The serum alkaline phosphatase in chronic infiltrative disease of the liver.Amer. J. Med. 21:850, 1956.
Gutman, A. B. Serum alkaline phosphatase activity in disease of the skeletal and hepatobiliary systems.Amer. J. Med. 27:875, 1959.
Hanger, F. H., andGutman, A. B. Postarsphenamine jaundice.J.A.M.A. 115:263, 1940.
Popper, H. Cholestatic hepatitis.Gastroenterology 31:683, 1956.
Schaffner, F., andKniffen, J. C. Electron microscopy as related to hepatotoxicity.Ann. N. Y. Acad. Sci. 104:847, 1963.
Popper, H., Schaffner, F., Rubin, E., Barka, T., andParnetto, F. Mechanisms of intrahepatic cholestasis in drug induced hepatic injury.Ann. N. Y. Acad. Sci. 104:988, 1963.